Basilea Pharmaceutica Ltd (BPMUF)
44.45
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Basilea Pharmaceutica Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| December 29, 2023 | 29.47 |
| December 28, 2023 | 29.47 |
| December 27, 2023 | 29.47 |
| December 26, 2023 | 29.47 |
| December 22, 2023 | 29.47 |
| December 21, 2023 | 29.47 |
| December 20, 2023 | 29.47 |
| December 19, 2023 | 29.47 |
| December 18, 2023 | 29.47 |
| December 15, 2023 | 29.47 |
| December 14, 2023 | 29.47 |
| December 13, 2023 | 29.47 |
| December 12, 2023 | 29.47 |
| December 11, 2023 | 29.47 |
| December 08, 2023 | 29.47 |
| December 07, 2023 | 29.47 |
| December 06, 2023 | 29.47 |
| December 05, 2023 | 29.47 |
| December 04, 2023 | 29.47 |
| December 01, 2023 | 29.47 |
| November 30, 2023 | 29.47 |
| November 29, 2023 | 29.47 |
| November 28, 2023 | 29.47 |
| November 27, 2023 | 29.47 |
| November 24, 2023 | 29.47 |
| Date | Value |
|---|---|
| November 22, 2023 | 29.47 |
| November 21, 2023 | 29.47 |
| November 20, 2023 | 29.47 |
| November 17, 2023 | 29.47 |
| November 16, 2023 | 29.47 |
| November 15, 2023 | 29.47 |
| November 14, 2023 | 29.47 |
| November 13, 2023 | 29.47 |
| November 10, 2023 | 29.47 |
| November 09, 2023 | 29.47 |
| November 08, 2023 | 29.47 |
| November 07, 2023 | 29.47 |
| November 06, 2023 | 29.47 |
| November 03, 2023 | 29.47 |
| November 02, 2023 | 29.47 |
| November 01, 2023 | 29.47 |
| October 31, 2023 | 29.47 |
| October 30, 2023 | 29.47 |
| October 27, 2023 | 29.47 |
| October 26, 2023 | 29.47 |
| October 25, 2023 | 29.47 |
| October 24, 2023 | 29.47 |
| October 23, 2023 | 29.47 |
| October 20, 2023 | 29.47 |
| October 19, 2023 | 29.47 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
29.47
Minimum
Oct 18 2023
35.94
Maximum
Jun 30 2023
33.34
Average
35.94
Median
Jun 30 2023
Price to Book Value Benchmarks
| AC Immune SA | 1.251 |
| CRISPR Therapeutics AG | 2.572 |
| Addex Therapeutics Ltd | 7.210 |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | 0.6866 |
Price to Book Value Related Metrics
| PE Ratio | 66.07 |
| PS Ratio | 3.246 |
| Price to Free Cash Flow | 39.34 |
| Price | 44.45 |
| Earnings Yield | 1.51% |
| Market Cap | 533.48M |
| Operating PE Ratio | 23.76 |
| Normalized PE Ratio | 66.07 |